首页> 中文期刊>吉林医学 >索利那新联合地西泮治疗女性膀胱过度活动症的疗效观察

索利那新联合地西泮治疗女性膀胱过度活动症的疗效观察

     

摘要

Objective To observe the new solid joint stability in treatment of female bladder disease excessive activity. Method 108 ca-ses of urinary bladder excessive activity who were randomly selected into group A and group B A group was given solifenacin with 5 mg,1 times a day,valium 2. 5 mg,twice a day,the course of eight weeks,B group was given anisodamine piece,3 times a day,5 mg a time,valium 2. 5 mg twice a day,the course of eight weeks. Before and after treatment in patients with complete voiding diary,excessive activity in bladder disease score( OABSS)as the observation indexes. Results After 8 weeks treatment,the symptoms of all patients after treatment had different degrees of improvement,compared before and after treatment the difference was statistically significant(P<0. 05). Conclusion Solifenacin combined with Diazepam in treatment of female bladder disease abundance activities is a safe and effective treatment method,plays an impor-tant role in improving the life quality of patients.%目的:观察索利那新联合地西泮治疗女性膀胱过度活动症的有效性和安全性。方法:随机选取108例膀胱过度活动症患者,分成A组和B组。A组给予口服索利那新5 mg,1次/d,地西泮2.5 mg,2次/d,疗程8周。B组口服山莨菪碱片,3次/d,5 mg/次,地西泮2.5 mg,2次/d,疗程8周。患者治疗前后填写排尿日记,以膀胱过度活动症评分( OABSS)为观察指标。结果:经过8周治疗,所有患者A组和B组治疗后较治疗前症状均有不同程度的好转,治疗前后对比差异有统计学意义( P<0.05)。结论:索利那新联合地西泮较山莨菪碱疗效好,是治疗女性膀胱多度活动症是一种安全、有效的治疗手段,对提高患者的生活质量具有重要作用。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号